Skip to main content

Times of India reports Safir Anand has been invited by the President of the Fashion Design Council of India (FDCI) to its Board of Directors. Sunil Sethi, President, FDCI, remarked “having a specialist on board will help the members with legal action required in such cases.”

Safir Anand has on previous occasions highlighted the need for designers to be more conscious of their intellectual property rights. His role as an FDCI board member is envisaged as one of finding solutions to solve the “copyright issues” prevalent in the fashion industry. His legal expertise and knowledge of the industry will further facilitate action against plagiarism.

The sensitivities of ‘drawing inspiration’ from existing fashion are complex, but designers can be proactive in protecting their creations. The Fashion Dossier discussed in simple and practical terms how trademark, copyright and design laws protect originality. In a talk on “Plagiarism in Fashion“, Safir Anand had joined Nonita Kalra and J. J. Valaya to discuss the measure designers can take to protect their IP.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 27, 2026

When a pharmaceutical company develops a new formulation of an existing drug, is it creating a genuine innovation or extending its monopoly over a medicine

Evergreening or Genuine Innovation? The Patentability of New Drug Formulations in India
News & Updates, Thought Leadership
•
Oct 23, 2026

Imagine a researcher using artificial intelligence to identify a new material, a pharmaceutical team using machine learning to discover a promising compound,

Can AI-Assisted Inventions Be Patented in India?
News & Updates, Thought Leadership
•
Oct 20, 2026

Every time someone publishes an article, uploads a photograph, releases a song or shares research online, they contribute to an expanding body of human

Who Owns Internet’s Knowledge? Copyright, AI Training and Indian Law
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions